News

ERS Virtual Congress 2020

27. August 2020

The 30th anniversary of the ERS Congress will be an innovative and interactive virtual event. It will take place on 7–9 September, 2020. The annual Congress is a showcase of excellence across the entire field of respiratory medicine. ERS is committed to supporting the respiratory community to connect and share the latest ...

Minister Dr. Nicole Hoffmeister-Kraut at Xenios AG

13. July 2020

The Minister Dr. Nicole Hoffmeister-Kraut, Minister of Economic Affairs of Baden-Württemberg, visited Xenios AG on Thursday. During her visit to the city of Heilbronn, Dr. Hoffmeister-Kraut wanted to get a personal impression of how the medical technology manufacturer is getting through the corona crisis. Other guests included various state and ...

ECMO becomes crucial therapy in battle against COVID-19 in Europe

30. April 2020

Xenios consoles as lifesavers As the coronavirus spreads and infections with COVID-19 further increase throughout Europe, ECMO therapy turns out to be a necessary option for patients with severe courses. Xenios AG, a subsidiary of Fresenius Medical Care, provides ECMO consoles that can be used for the treatment of patients who ...

Video: How do artificial lungs work?

22. April 2020

Xenios had the chance to work together with VRM GmbH & Co. KG, based in Mainz, Germany, to shoot a video about the function of an artificial lung and to explain the importance and the current training situation in China and the USA. VRM is one of the most important ...

Fresenius Medical Care sends more Novalung consoles for ECMO to support Wuhan in battle against COVID-19

19. March 2020

Fresenius Medical Care is again supplying medical equipment that is urgently needed to combat the COVID-19 outbreak in Wuhan, including 16 Novalung® consoles, the second such shipment to the Chinese city. Novalung is an extracorporeal membrane oxygenation (ECMO) system from Fresenius Medical Care that pumps and oxygenates a patient’s blood. ...

Novalung System receives US FDA Clearance

26. February 2020

The US FDA (Food and Drug Administration) has granted 510(k) approval to Fresenius Medical Care North America and Xenios, a Fresenius Medical Care company, for long-term use of its Novalung system for patients with acute lung failure or acute cardiopulmonary failure. The FDA announced this on Friday evening. With class ...

Events

22. – 26. October
ESICM LIVES 2022

35th ESICM's (European Society Of Intensive Care Medicine) annual congress - LIVES